Edition:
United States
Pictures | Sun Apr 1, 2012 | 5:19am EDT

Insight: Chasing cheaper cancer drugs

A girl suffering from cancer rests inside the children's ward at the Cancer Centre Welfare Home and Research Institute in Kolkata March 16, 2012. India, a country with a long history of making cheap off-patent drugs and a sometimes brittle relationship with Western drugmakers, has finally lost patience. New Delhi shocked the global drugs industry in March by effectively ending Bayer's monopoly on kidney and liver cancer drug Nexavar and issuing its first-ever compulsory licence, allowing local generic firm Natco Pharma to produce and sell the drug cheaply in India. In a move to head off the same threat to its patented drugs, Roche, the world's biggest maker of cancer medicines, plans to offer significantly cheaper locally branded versions of two other cancer treatments, Herceptin and MabThera, under an alliance with Emcure Pharmaceuticals. Picture taken March 16, 2012. REUTERS/Rupak De Chowdhuri/Files

A girl suffering from cancer rests inside the children's ward at the Cancer Centre Welfare Home and Research Institute in Kolkata March 16, 2012. India, a country with a long history of making cheap off-patent drugs and a sometimes brittle...more

A girl suffering from cancer rests inside the children's ward at the Cancer Centre Welfare Home and Research Institute in Kolkata March 16, 2012. India, a country with a long history of making cheap off-patent drugs and a sometimes brittle relationship with Western drugmakers, has finally lost patience. New Delhi shocked the global drugs industry in March by effectively ending Bayer's monopoly on kidney and liver cancer drug Nexavar and issuing its first-ever compulsory licence, allowing local generic firm Natco Pharma to produce and sell the drug cheaply in India. In a move to head off the same threat to its patented drugs, Roche, the world's biggest maker of cancer medicines, plans to offer significantly cheaper locally branded versions of two other cancer treatments, Herceptin and MabThera, under an alliance with Emcure Pharmaceuticals. Picture taken March 16, 2012. REUTERS/Rupak De Chowdhuri/Files
Close
1 / 2
A woman with cancer sits on a pavement outside the Tata Memorial Hospital in Mumbai March 15, 2012. India, a country with a long history of making cheap off-patent drugs and a sometimes brittle relationship with Western drugmakers, has finally lost patience. New Delhi shocked the global drugs industry in March by effectively ending Bayer's monopoly on kidney and liver cancer drug Nexavar and issuing its first-ever compulsory licence, allowing local generic firm Natco Pharma to produce and sell the drug cheaply in India.In a move to head off the same threat to its patented drugs, Roche, the world's biggest maker of cancer medicines, plans to offer significantly cheaper locally branded versions of two other cancer treatments, Herceptin and MabThera, under an alliance with Emcure Pharmaceuticals. Picture taken March 15, 2012. REUTERS/Vivek Prakash/Files

A woman with cancer sits on a pavement outside the Tata Memorial Hospital in Mumbai March 15, 2012. India, a country with a long history of making cheap off-patent drugs and a sometimes brittle relationship with Western drugmakers, has finally lost...more

A woman with cancer sits on a pavement outside the Tata Memorial Hospital in Mumbai March 15, 2012. India, a country with a long history of making cheap off-patent drugs and a sometimes brittle relationship with Western drugmakers, has finally lost patience. New Delhi shocked the global drugs industry in March by effectively ending Bayer's monopoly on kidney and liver cancer drug Nexavar and issuing its first-ever compulsory licence, allowing local generic firm Natco Pharma to produce and sell the drug cheaply in India.In a move to head off the same threat to its patented drugs, Roche, the world's biggest maker of cancer medicines, plans to offer significantly cheaper locally branded versions of two other cancer treatments, Herceptin and MabThera, under an alliance with Emcure Pharmaceuticals. Picture taken March 15, 2012. REUTERS/Vivek Prakash/Files
Close
2 / 2

Next Slideshows

Myanmar's democratic spring

Myanmar prepares to vote in only its third election in 50 years, a test of its nascent democratic credentials.

Mar 30 2012

Photos of the week

Our top photos from the past week.

Mar 30 2012

Falklands War: the Argentine side

A look at the war over the Falkland Islands (Islas Malvinas) from the Argentine side.

Mar 30 2012

London's little Venice

Largely hidden behind buildings, Regent's Canal sneaks its way through a rich collage of urban landscapes, from fashionable East London to Limehouse Basin.

Mar 30 2012

MORE IN PICTURES

President Trump's first foreign trip

President Trump's first foreign trip

Donald Trump, on his first overseas trip as president, is on a nine-day journey through the Middle East and Europe.

Billboard Music Awards

Billboard Music Awards

Highlights from the Billboard Music Awards.

Best of Cannes

Best of Cannes

Highlights from the 70th Cannes Film Festival on the French Riviera.

Endgame in Mosul

Endgame in Mosul

Seven months into the campaign to recapture Mosul, Islamic State militants are besieged in its northwestern corner.

Curtain closes on Ringling Brothers circus

Curtain closes on Ringling Brothers circus

The clowns, animal acts and acrobats of the storied Ringling Bros and Barnum & Bailey Circus take their final bow.

North Korea's rockets

North Korea's rockets

Inside North Korea's secretive weapons program.

Trump makes historic visit to Western Wall

Trump makes historic visit to Western Wall

President Trump becomes the first sitting U.S. president to pray at Jerusalem's Western Wall.

Billboard red carpet

Billboard red carpet

Style from the Billboard Music Awards red carpet.

Pippa Middleton marries

Pippa Middleton marries

Pippa Middleton, younger sister of Kate, Britain's Duchess of Cambridge, was married in a small English country church surrounded by royals and celebrities but those hoping for a dash of Hollywood were left in the cold.

Trending Collections

Pictures

Podcast